Deep Neural Network Approaches for Closed-Loop Deep Brain Stimulation
Primary Purpose
Parkinson Disease
Status
Enrolling by invitation
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Brain signal data collection
Sponsored by
About this trial
This is an interventional basic science trial for Parkinson Disease
Eligibility Criteria
Inclusion Criteria:
- Subjects scheduled for DBS implantation, as determined by the clinical multidisciplinary movement disorders board with definitive diagnosis of Parkinson's disease
- Subjects able to provide informed consent and comply with task instructions.
- Subjects 18-85 years old
Exclusion Criteria:
1. Non-English-speaking subjects
Sites / Locations
- Massachusetts General Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Brain signal data collection
Arm Description
Collection of brain data during deep brain stimulation
Outcomes
Primary Outcome Measures
The number of subjects providing interpretable electrophysiological data during DBS surgery
The number of subjects providing interpretable electrophysiological data during DBS surgery
Secondary Outcome Measures
Full Information
NCT ID
NCT04277689
First Posted
January 8, 2020
Last Updated
August 17, 2023
Sponsor
Massachusetts General Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04277689
Brief Title
Deep Neural Network Approaches for Closed-Loop Deep Brain Stimulation
Official Title
Deep Neural Network Approaches for Closed-Loop Deep Brain Stimulation
Study Type
Interventional
2. Study Status
Record Verification Date
August 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
June 10, 2021 (Actual)
Primary Completion Date
February 2025 (Anticipated)
Study Completion Date
February 2026 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Massachusetts General Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
In this research study the researchers want to learn more about brain activity related to speech perception and production in patients with Parkinson's Disease who are undergoing deep brain stimulation (DBS).
Detailed Description
Deep brain stimulation (DBS) is the gold-standard treatment for patients with medication resistant motor complications of Parkinson's disease (PD) and provides the only opportunity to record and stimulate in the human basal ganglia. Most recently, the concurrent use of research electrocorticography (ECoG) during DBS surgery, including pioneering work from Pittsburgh, has further enabled basic neuroscience investigation of human cortical-subcortical network dynamics. The discovery that aberrant synchronization of rhythmic neuronal activity recorded in PD patients is suppressed by DBS has advanced the concept that measures associated with pathological activity may be used as biomarkers to control the delivery of DBS therapy. Pilot studies of aDBS in PD have reported promising clinical results from triggering DBS stimulation when the signal recorded from the DBS electrode showed a high level of oscillatory power in the beta frequency range (13 - 35 Hz). That approach, however, has important limitations. Most importantly, beta power recorded from the DBS lead is suppressed by movement including PD tremor, its detection is highly dependent on lead location and the recording montage needed to record during stimulation is incompatible with directional current steering, a recent innovation employing segmented stimulation contacts. The inherent complexity of the increased parameter space through DBS innovations also overwhelms standard programming techniques. Finally, use of additional biomarker signals (e.g., recorded from cortex) is likely to improve the ability to adaptively control DBS for disorders marked by complex multidimensional symptomatologies such as PD. The current proposal will establish methods for overcoming these limitations by developing techniques for multi-feature classification from ECoG recordings, using advanced machine learning algorithms.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson Disease
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Brain signal data collection
Arm Type
Experimental
Arm Description
Collection of brain data during deep brain stimulation
Intervention Type
Procedure
Intervention Name(s)
Brain signal data collection
Intervention Description
Collection of speech related electrophysiological data at the time of DBS.
Primary Outcome Measure Information:
Title
The number of subjects providing interpretable electrophysiological data during DBS surgery
Description
The number of subjects providing interpretable electrophysiological data during DBS surgery
Time Frame
Duration of single DBS surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subjects scheduled for DBS implantation, as determined by the clinical multidisciplinary movement disorders board with definitive diagnosis of Parkinson's disease
Subjects able to provide informed consent and comply with task instructions.
Subjects 18-85 years old
Exclusion Criteria:
1. Non-English-speaking subjects
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robert M Richardson, MD, PhD
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Massachusetts General Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Deep Neural Network Approaches for Closed-Loop Deep Brain Stimulation
We'll reach out to this number within 24 hrs